A recent analysis of the LoDoCo2 (Low-Dose Colchicine 2) trial suggests that taking a low daily dose of colchicine may reduce ...

In The Lancet Rheumatology, Edoardo Cipolletta and colleagues present an observational study comparing the risk of cardiovascular events in patients with gout initiating urate-lowering therapy with or ...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking ...

Many influencers claim the medical community ignores inflammation, but countless millions have been spent studying the ...

4) CLEAR SYNERGY, dual trials on the use of spironolactone vs. placebo and colchicine vs. placebo in patients with myocardial infarction, and 5) Project My Heart Your Heart, developing a protocol of ...

Studies have suggested that IL-1 beta activation leads to IL-6 production, which could provide an alternative to current therapeutic strategies.

Ruby red grapefruit (Image by Brent Hofacker, Shutterstock) In the late 1930s, while experimenting with chemical mutagens, it ...

Diagnosing osteoarthritis often occurs in the late stages when cartilage degradation is severe, making it difficult to ...

A UVA Health cardiologist was recently featured alongside NHL Hall-of-Famer Henrik Lundqvist in a national campaign to raise ...

（吉隆坡19日讯）高庭谕令25名答辩人，包括首相拿督斯里安华、联邦政府和世界卫生组织（WHO），在明年1月20日前对一宗冠病疫苗集体诉讼案提交抗辩。

Other defendants include Prime Minister Anwar Ibrahim, the World Health Organization and former prime ministers Muhyiddin ...

近日，山东学者进行的一项Meta分析表明，动脉粥样硬化性心血管疾病（ASCVD）患者使用秋水仙碱有助于降低缺血性脑卒中风险，尤其长期使用后。 不过研究者表示，鉴于现有试验结果的不一致性，还需要进一步的研究来证实。